Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

By S. Schulman, A. Kakkar, Samuel Z. Goldhaber, S. Schellong, H. Eriksson, P. Mismetti, A. Christiansen, J. Friedman, F. Le Maulf, N. Peter and 1 more. Circulation, 2014

912 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Hematology, Internal Medicine

View Paper: https://www.semanticscholar.org/paper/0ac527426c40e5fb2c65c4ee6f874425a7148de1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Hematology

S. Konstantinides

In Internal Medicine

Citations in the corpus

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. (2012, methodology): “Pooled analysis of Schulman et al(20) (RE-COVER I) and Schulman et al(24) (RE-COVER II) performed by Schulman et al.(24)”
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). (2018, background): “9 Currently receiving cancer treatment§ 142 (70) 140 (69) Chemotherapy 120 (85) 113 (81) Radiotherapy 10 (7) 6 (4) Targeted therapy 22 (15) 21 (15) Endocrine therapy 15 (11) 15 (11) Primary tumor type Bladder 4 (2) 10 (5) Brain 2 (1) 1 (1) Breast 20 (10) 20 (10) Cancer unknown primary 3 (2) 3 (1) Ch”
[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. (2014, neutral): “11).(294) In the EINSTEIN-DVT and EINSTEIN-PE trials,(295,296) single oral drug treatment with the direct factor Xa inhibitor rivaroxaban (15 mg twice daily for 3 weeks, followed by 20 mg once daily) was tested against enoxaparin/warfarin in patients with VTE using a randomized, open-label, non-infe”
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (2019, background): “lactation, and in patients with antiphospholipid antibody syndrome.(260,261,312) 314 III C”
ESC Guidelines on the diagnosis and management of acute pulmonary embolism (2014, background): “11).(294) In the EINSTEIN-DVT and EINSTEIN-PE trials,(295,296) single oral”